The U.S. Patent and Trademark Office has agreed to re-evaluate the validity of three core stem cell patents held by a Wisconsin foundation that has been accused of strangling U.S. research in the field with sweeping demands for license fees and royalties from other investigators.
Office of Strategic Communication